Molecular bases of the poor response of liver cancer to chemotherapy-Reference-Cited by-同舟云学术

Molecular bases of the poor response of liver cancer to chemotherapy

Published:2018-06 Issue:3 Volume:42 Page:182-192
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Marin Jose J.G.,Briz Oscar,Herraez Elisa,Lozano Elisa,Asensio Maitane,Di Giacomo Silvia,Romero Marta R.,Osorio-Padilla Luis M.,Santos-Llamas Ana I.,Serrano Maria A.,Armengol Carolina,Efferth Thomas,Macias Rocio I.R.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference149 articles.

1. Molecular bases of liver cancer refractoriness to pharmacological treatment;Marin;Curr Med Chem,2010

2. Further understanding of mechanisms involved in liver cancer chemoresistance;Briz;Hepatoma Res,2017

3. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors;Martinez-Becerra;Mol Pharm,2012

4. Strategies for overcoming chemotherapy resistance in enterohepatic tumours;Marin;Curr Mol Med,2010

5. Chemoresistance and chemosensitization in cholangiocarcinoma;Marin;Biochim Biophys Acta,2018

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IMPDH2 suppression impedes cell proliferation by instigating cell cycle arrest and stimulates apoptosis in pediatric hepatoblastoma;Journal of Cancer Research and Clinical Oncology;2024-08-01

2. Strategies to enhance the response of liver cancer to pharmacological treatments;American Journal of Physiology-Cell Physiology;2024-07-01

3. Role of cholesterol homeostasis in MASH-driven hepatocellular carcinoma: not just a neutral fat;Exploration of Digestive Diseases;2024-06-14

4. Sustainable gambogic acid release via pH/Redox Dual-Responsive C60-Modified magnetic mesoporous nanospheres for antitumor therapy;Materials & Design;2024-05

5. Network pharmacology approach and experimental verification of salidroside in the treatment of hepatocellular carcinoma;2023-12-06